NCT03674203View on ClinicalTrials.gov

Efficacy of Platelet-rich Plasma in Treatment of Melasma

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 1, 2017

Primary Completion Date

May 31, 2018

Study Completion Date

July 31, 2018

Conditions
Melasma
Interventions
BIOLOGICAL

Platelet-Rich Plasma

1 ml of PRP was distributed in the papillary dermis of the face, repeating the dose at 15 and 30 days.

Trial Locations (1)

44340

Western Medical Center, Mexican Institute of Social Security, Guadalajara

All Listed Sponsors
lead

Instituto Mexicano del Seguro Social

OTHER_GOV

NCT03674203 - Efficacy of Platelet-rich Plasma in Treatment of Melasma | Biotech Hunter | Biotech Hunter